Indian panel reportedly will review compulsory cancer drug licensing

01/14/2013 | Economic Times (India), The

The Indian government has created a panel to review issues tied to compulsory licensing and whether generic versions of three cancer drugs can be released, according to a source. Governments can let drugmakers produce patented medicines without consent from patent-holders under the World Trade Organization's compulsory licensing provision. The move could trigger new disputes in the area of intellectual property, experts said.

View Full Article in:

Economic Times (India), The

Published in Brief: